International Stem Cell Corporation to Present at 12th Annual BIO Investor Forum October 8-9th, 2013
(firmenpresse) - CARLSBAD, CA -- (Marketwired) -- 09/26/13 -- International Stem Cell Corporation (OTCQB: ISCO) (), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that it will participate in the 12th Annual BIO Investor Forum hosted by the Biotechnology Industry Organization (BIO). The conference is being held October 8-9th, 2013, at the Palace Hotel in San Francisco, CA.
Dr. Simon Craw, Executive Vice President, will provide an overview of the Company's business during the live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.
Date: Wednesday, October 9, 2013
Time: 2:00 p.m. Pacific Time
Location: Palace Hotel, Presidio Room
Follow the official conference feed on Twitter, and join the conversation by using #BIF13.
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial background with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology (), and stem cell-based skin care products through its subsidiary Lifeline Skin Care (). More information is available at or follow us on Twitter (at)intlstemcell.
To receive ongoing corporate communications, please click on the following link:
The 12th Annual is an international investor conference focused on private and emerging public biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities. In addition, the BIO Investor Forum draws business development executives from leading global pharmaceutical and established biotechnology companies.
International Stem Cell Corporation
Dr. Simon Craw
Executive Vice President
Phone: 760-940-6383
Email:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 26.09.2013 - 12:30 Uhr
Sprache: Deutsch
News-ID 300505
Anzahl Zeichen: 0
contact information:
Town:
CARLSBAD, CA
Kategorie:
Drugs
Diese Pressemitteilung wurde bisher 363 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"International Stem Cell Corporation to Present at 12th Annual BIO Investor Forum October 8-9th, 2013"
steht unter der journalistisch-redaktionellen Verantwortung von
International Stem Cell Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
